SCHEMBL176960

SCHEMBL176960

CC(C)N(Cc1ccc(-c2ccc(C=O)cc2)s1)c1ccc(F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.38
S1PR1 P21453 1/20 0.38
PTGS1 P23219 1/20 0.36
RORC P51449 8/20 0.35
RORA P35398 2/20 0.35
NR1H2 P55055 2/20 0.35
NR1H3 Q13133 2/20 0.35
RORB Q92753 2/20 0.35
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP3 P08254 1/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35
MMP13 P45452 1/20 0.35
MMP14 P50281 1/20 0.35
ALDH1A1 P00352 2/20 0.34
ALDH3A1 P30838 1/20 0.34
ALDH1A3 P47895 1/20 0.34
KDM4E B2RXH2 3/20 0.33
NPC1 O15118 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL177116 0.80 S1PR1 (0.55) TAAR1S1PR1PTGS1MMP1MMP2
SCHEMBL15511600 0.77 S1PR1 (0.46) TAAR1S1PR1RORCRORANR1H2
SCHEMBL177055 0.77 S1PR1 (0.38) TAAR1S1PR1RORCMMP1MMP2
SCHEMBL177244 0.77 ACKR3 (0.44) TAAR1S1PR1RORCHSD17B1HSD17B2
SCHEMBL177064 0.76 S1PR1 (0.38) TAAR1S1PR1RORCRORANR1H2
SCHEMBL177580 0.75 S1PR1 (0.42) S1PR1RORCMMP1MMP2MMP3
SCHEMBL177100 0.72 S1PR1 (0.38) TAAR1S1PR1RORCALDH1A1SMN1; SMN2
SCHEMBL177226 0.69 ALDH1A1 (0.39) TAAR1S1PR1ALDH1A1ALDH3A1ALDH1A3
SCHEMBL14939969 0.68 ALDH1A1 (0.59) ALDH1A1ALDH3A1ALDH1A3HPGDCYP2A6
SCHEMBL177484 0.67 CYP2A6 (0.47) PTGS1ALDH1A1KDM4EHPGDCYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9707205-B2 S1P receptors modulators and their use thereof AKAAL PHARMA PTY LTD. (AU) 2017-07-18 US disclosed
EP-2344484-B1 S1P RECEPTORS MODULATORS AND USE THEREOF AKAAL PHARMA PTY LTD (AU) 2016-06-08 EP disclosed
US-20160038455-A1 S1P RECEPTORS MODULATORS AND THEIR USE THEREOF AKAAL PHARMA PTY LTD. (AU) 2016-02-11 US disclosed
US-9193716-B2 S1P receptors modulators and their use thereof AKAAL PHARMA PTY LTD. (AU) 2015-11-24 US disclosed
US-20140066427-A1 S1P Receptors Modulators and Their Use Thereof AKAAL PHARMA PTY LTD. (AU) 2014-03-06 US disclosed
US-8592399-B2 S1P receptors modulators and their use thereof AKAAL PHARMA PTY LTD. (AU) 2013-11-26 US disclosed
US-20110318388-A1 S1P Receptors Modulators and Their Use Thereof AKAAL PHARMA PTY LTD (AU) 2011-12-29 US disclosed
EP-2344484-A1 S1P RECEPTORS MODULATORS AND THEIR USE THEREOF Akaal Pharma Pty Ltd (AU) 2011-07-20 EP disclosed
WO-2010043000-A1 S1P RECEPTORS MODULATORS AND THEIR USE THEREOF AKAAL PHARMA PTY LTD (AU) 2010-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160038455-A1 S1P RECEPTORS MODULATORS AND THEIR USE THEREOF S1PR1, S1PR5, S1PR2 TAAR1 262/4885S1PR1 1/4885PTGS1 670/4885
US-20110318388-A1 S1P Receptors Modulators and Their Use Thereof S1PR1, S1PR5, S1PR2 TAAR1 262/4885S1PR1 1/4885PTGS1 670/4885
US-20140066427-A1 S1P Receptors Modulators and Their Use Thereof S1PR1, S1PR2, S1PR5 TAAR1 147/4885S1PR1 1/4885PTGS1 830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.